About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Clinical Trials News » Bristol-Myers and Johnson & Johnson to Study Combination Therapy for Hepatitis C

Bristol-Myers and Johnson & Johnson to Study Combination Therapy for Hepatitis C

by Dr. Trupti Shirole on Dec 4 2011 5:03 PM

Bristol-Myers and Johnson & Johnson to Study Combination Therapy for Hepatitis C

Bristol-Myers Squibb Co. will collaborate with a unit of Johnson & Johnson to study a potential combination therapy for chronic hepatitis C.

The companies will test the potentially positive effects of combining Johnson & Johnson's drug TMC435 with Bristol-Myers Squibb's daclatasvir. The clinical trials will begin in the first half of 2012 and will include a combination of the two drugs, the drugs plus pegylated interferon and ribavirin, and the drugs plus ribavirin.

Hepatitis C - Causes, Symptoms, Diagnosis, Treatment, Complications, Prevention

Hepatitis C - Causes, Symptoms, Diagnosis, Treatment, Complications, Prevention
Hepatitis C is a contagious viral disease affecting the liver that is caused by the hepatitis C virus.

The terms of their partnership were not disclosed.

Source-Medindia

Hepatitis A - Causes, Symptoms, Diagnosis, Treatment

Hepatitis A - Causes, Symptoms, Diagnosis, Treatment
Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. Hepatitis A vaccine is available that is 95% effective in preventing the disease.

Hepatitis B-Causes-Symptoms-Diagnosis-Treatment-Vaccination-FAQs

Hepatitis B-Causes-Symptoms-Diagnosis-Treatment-Vaccination-FAQs
Hepatitis B is inflammation of the liver due to infection with the hepatitis B virus.

Safe Sex

Safe Sex
Sex is fun but involves health risks such as sexually transmitted diseases (STDs or unplanned pregnancy specially in those who have multiple partners or in those having unprotected sex.

Recommended Readings

Tests for Hepatitis

Tests for Hepatitis

Hepatitis is an inflammation of the liver. Hepatitis virus panel is a series of blood tests to diagnose infections caused by hepatitis A, B and C viruses.

Aplastic Anemia

Aplastic Anemia

Aplastic anemia (AA) is a term that refers to a condition where the body fails to produce enough blood cells.

Vasculitis

Vasculitis is an inflammation of the blood vessels of the body that can affect people of all ages; it is usually due to an autoimmune disorder

Hepatitis B

Hepatitis B is inflammation of the liver due to infection with the hepatitis B virus.

Hepatitis C

Hepatitis C is a contagious viral disease affecting the liver that is caused by the hepatitis C virus.

Combination Therapy for High Blood Pressure

Combination Therapy for High Blood Pressure

Anti-hypertensive agents are still the treatment drugs for hypertension but recent advances indicate that combination therapy may be a more effective form of treatment.

Latest Clinical Trials News

TB Vaccine MTBVAC Enters Clinical Trials in India

TB Vaccine MTBVAC Enters Clinical Trials in India

Bharat Biotech, with Biofabri, is trialing MTBVAC, the first live attenuated vaccine derived from a human strain of Mycobacterium tuberculosis.

Rucaparib's Impact on Progression-Free Survival in Uterine Cancer Patients

Rucaparib's Impact on Progression-Free Survival in Uterine Cancer Patients

Clinical trials show encouraging results for individuals diagnosed with metastatic and recurrent uterine cancer, also referred to as endometrial cancer.

UK Launches First Human Trial for Nipah Virus Vaccine

UK Launches First Human Trial for Nipah Virus Vaccine

Utilizing the ChAdOx1 platform, the researchers developed ChAdOx1 NipahB, a vaccine for the Nipah virus.

Plant Chloroplasts Offer Hope for Huntington's Disease Treatment

Plant Chloroplasts Offer Hope for Huntington's Disease Treatment

A chloroplast plant enzyme - stromal processing peptidase, helps treat Huntington's disease by preventing protein clumping.

‘Artificial Wombs’ In Human Trials Await FDA Approval

‘Artificial Wombs’ In Human Trials Await FDA Approval

FDA approval is sought for “artificial womb” clinical trials (mimicking lamb trials) in humans, that can potentially reduce mortality in premature babies.

Advertisement